Daejeon, South Korea

Seong-Hwan Park

This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seong-Hwan Park. Retrieved from https://idiyas.com/inventor/seong-hwan-park-66sz23yo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seong-Hwan Park: Inventor in Cancer Research

Introduction

Seong-Hwan Park is an inventor associated with Daejeon, South Korea, and the Korea Research Institute of Bioscience and Biotechnology. His work includes a patent concerning cinnamamide derivatives and their potential use in cancer prevention or treatment.

Latest Patents

Park is listed as an inventor on one patent, 1 patent: “Cinnamamide Derivatives and Use Thereof.” The disclosure describes novel cinnamamide derivatives and their proposed use in preventing or treating cancer.

Career Highlights

Park’s patent work is connected to the Korea Research Institute of Bioscience and Biotechnology, a research institution based in South Korea. The patent reflects research into compounds with potential applications in cancer-related therapies.

Collaborations

The patent lists Byoung-Mog Kwon and Dong Cho Han among Park’s collaborators.

Conclusion

Seong-Hwan Park’s recorded invention focuses on cinnamamide derivatives and their potential role in cancer prevention or treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…